JAKELYN ALFARO: Open Payments
NPI 1902431232 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 23 payments from 11 companies in 2025. Trend: 2023 $296 · 2024 $547 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $159 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| TOLMAR, INC. | 2 | $37 |
| Antares Pharma, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $33 |
| Amgen Inc. | 2 | $31 |
| Renalytix AI, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Wegovy, AIRSUPRA, JATENZO, XYOSTED, Veozah, BREZTRI, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, Saxenda.
Industry payments across TX — which companies pay providers there.
